Plexin-B3 activators are a specialized category of chemical compounds that interact with and promote the functional activity of Plexin-B3, a protein encoded by the PLXNB3 gene. This protein plays a pivotal role in the semaphorin signaling pathway, which is crucial for various biological processes including axon guidance, cell migration, and immune responses. Activators of Plexin-B3 typically engage with its intracellular domain, which facilitates signal transduction across the cell membrane, leading to downstream effects within the cell. Through precise molecular interactions, these activators may stabilize the active conformation of Plexin-B3 or enhance its affinity for its natural ligand, semaphorin, thereby amplifying the signaling cascade. The activation of Plexin-B3 often culminates in the modulation of Rho family GTPases, a group of proteins that regulate the cytoskeleton and, consequently, cell morphology and motility.
The biochemical activation mechanisms of Plexin-B3 activators encompass direct binding or allosteric modulation, which can result in an increased signaling output from the Plexin-B3 protein. The chemical activators may influence the guanine nucleotide exchange factors (GEFs) or GTPase-activating proteins (GAPs) that directly interact with Plexin-B3, thereby modulating the activity of Rho GTPases in a manner that promotes cellular responses mediated by Plexin-B3. Since Plexin-B3 is involved in complex cellular processes, the activators are chosen for their ability to specifically enhance the signaling without altering the protein's expression levels. This selectivity ensures that the activators effectively increase the functional activity of Plexin-B3 by promoting its natural physiological role, rather than invoking a general increase in protein synthesis. By doing so, Plexin-B3 activators exert a targeted effect on the signaling pathways that rely on this protein, driving the cellular responses that are characteristic of Plexin-B3 function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
LPA acts through G protein-coupled receptors (GPCRs) to activate RhoA, a downstream effector that interacts with plexin-B3 to modulate cellular processes such as neurite retraction. | ||||||
Farnesyl pyrophosphate ammonium salt | 13058-04-3 | sc-200847 sc-200847A | 1 mg 5 mg | $478.00 $1977.00 | ||
As a substrate for farnesyltransferase, farnesyl pyrophosphate participates in the prenylation of RhoA, which is an essential post-translational modification for RhoA's interaction with plexin-B3. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P binds to its receptors, initiating signaling cascades that converge on the RhoA pathway, enhancing the RhoA-plexin-B3 signaling axis. | ||||||
Collagen IV | sc-29010 | 1 mg | $224.00 | 11 | ||
Collagen interaction with integrins initiates intracellular signaling cascades, including those involving RhoA, which can lead to the activation of plexin-B3-mediated pathways in cells. | ||||||
Fibronectin | sc-29011 sc-29011A | 1 mg 5 mg | $143.00 $504.00 | 94 | ||
Fibronectin, through its interaction with integrins, can activate focal adhesion kinase (FAK), which in turn can modulate RhoA activity and thus indirectly influence plexin-B3 signaling. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
By specifically inhibiting Rac1, NSC23766 can shift the balance of Rho GTPase activities towards RhoA, potentially enhancing the RhoA-plexin-B3 signaling pathway. | ||||||